Can Olanzapine (olanzapine) cause constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Olanzapine and Constipation

Yes, olanzapine can cause constipation as a common side effect, with constipation occurring in 9% of patients taking olanzapine compared to 3% in placebo groups. 1

Mechanism and Risk

  • Olanzapine causes constipation primarily through its anticholinergic (antimuscarinic) effects, which can lead to decreased gastrointestinal motility 1
  • Olanzapine has a moderate risk of causing constipation with a Report Odds Ratio (ROR) of 1.50 according to FDA Adverse Event Reporting System data 2
  • Constipation is among the most common adverse effects reported with olanzapine, alongside somnolence, weight gain, dizziness, and dry mouth 3
  • The anticholinergic properties of olanzapine affect multiple receptor types including muscarinic receptors (m1, m2, m3, m4), which play important roles in gastrointestinal function 4

Clinical Significance

  • Constipation is specifically listed in the FDA label as one of the most common adverse reactions associated with olanzapine monotherapy, occurring in 9% of patients compared to 3% in placebo groups 1
  • The FDA label specifically cautions about using olanzapine with caution in patients with constipation, paralytic ileus, or related conditions due to its anticholinergic effects 1
  • While olanzapine-induced constipation is generally less severe than that seen with clozapine (which has an ROR of 1.61), it still requires monitoring and management 2, 5

Management Approach

  • For patients on olanzapine experiencing constipation:

    • Increase fluid intake and encourage physical activity when appropriate 4
    • Increase dietary fiber if the patient has adequate fluid intake 4
    • Consider prophylactic laxatives for patients at high risk of constipation 4
    • For established constipation, stimulant laxatives such as bisacodyl 10-15 mg daily to three times daily can be used with a goal of one non-forced bowel movement every 1-2 days 4
  • For persistent constipation:

    • Add osmotic laxatives such as polyethylene glycol (1 capful/8 oz water twice daily) 4
    • Consider adding other laxatives such as lactulose, magnesium hydroxide, or magnesium citrate if needed 4
    • In severe cases, consider adding a prokinetic agent such as metoclopramide 4

Special Considerations

  • Patients with pre-existing gastrointestinal conditions may be at higher risk for developing constipation with olanzapine 1
  • The anticholinergic burden may be increased when olanzapine is combined with other medications with anticholinergic properties 1
  • Monitoring for constipation should be part of routine care for patients taking olanzapine, as patients may not always report this side effect 6
  • In some cases, severe constipation can lead to complications such as bowel obstruction if left untreated, though this is more commonly associated with clozapine than olanzapine 6, 5

Comparison to Other Antipsychotics

  • Olanzapine has a moderate risk of constipation (ROR = 1.50) compared to other atypical antipsychotics like clozapine (ROR = 1.61), quetiapine (ROR = 1.83), and paliperidone (ROR = 2.73) 2
  • Risperidone appears to have the least effect on gastrointestinal function among atypical antipsychotics (ROR = 0.71) 2
  • When constipation is a significant concern, considering an antipsychotic with lower anticholinergic properties may be appropriate 2, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.